These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14616825)

  • 41. Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.
    Kang MJ; Kim MS; Choi EH; Lee KE; Kim YK; Choi HJ
    Korean J Intern Med; 2007 Mar; 22(1):63-6. PubMed ID: 17427651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.
    Lee JH; Slifman NR; Gershon SK; Edwards ET; Schwieterman WD; Siegel JN; Wise RP; Brown SL; Udall JN; Braun MM
    Arthritis Rheum; 2002 Oct; 46(10):2565-70. PubMed ID: 12384912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cutaneous lupus induced by etanercept in rheumatoid arthritis].
    Abourazzak FE; Guggenbuhl P; Perdriger A; Meadeb J; Gando-Cocley N; Chevrant-Breton J; Hajjaj-Hassouni N; Chalès G
    Rev Med Interne; 2008 Sep; 29(9):744-7. PubMed ID: 18676065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V; Mergler S; Pleyer U
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic sarcoidosis induced by etanercept: first Brazilian case report.
    Unterstell N; Bressan AL; Serpa LA; Fonseca e Castro PP; Gripp AC
    An Bras Dermatol; 2013; 88(6 Suppl 1):197-9. PubMed ID: 24346918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etanercept. Immunex.
    Pugsley MK
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1725-31. PubMed ID: 11892935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angio-oedema in a patient treated with etanercept for rheumatoid arthritis.
    Sendur OF; Turan Y; Berkit IK; Tastaban E
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):488-90. PubMed ID: 19371261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.
    Zhou H
    J Clin Pharmacol; 2005 May; 45(5):490-7. PubMed ID: 15831771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cancer of the cheek in a patient under etanercept].
    Rousseau A; Taberne R; Siberchicot F; Fricain JC; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):306-8. PubMed ID: 19836037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etanercept: a review of its use in the management of rheumatoid arthritis.
    Dhillon S; Lyseng-Williamson KA; Scott LJ
    Drugs; 2007; 67(8):1211-41. PubMed ID: 17521223
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Etanercept (Enbrel) -- an update.
    Goffe B
    Skin Therapy Lett; 2004 Dec-2005 Jan; 9(10):1-4, 9. PubMed ID: 15657632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis: a case presentation and a literature review.
    Gifre L; Ruiz-Esquide V; Xaubet A; Gómez-Puerta JA; Hernández MV; Sanmartí R
    Arch Bronconeumol; 2011 Apr; 47(4):208-12. PubMed ID: 20638761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab.
    Mounach A; Ghazi M; Nouijai A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A
    Clin Exp Rheumatol; 2008; 26(6):1116-8. PubMed ID: 19210883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute ocular myositis occurring under etanercept for rheumatoid arthritis.
    Couderc M; Mathieu S; Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2014 Oct; 81(5):445-6. PubMed ID: 24746476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis.
    Benucci M; Li Gobbi F; Fossi F; Manfredi M; Del Rosso A
    J Clin Rheumatol; 2005 Feb; 11(1):47-9. PubMed ID: 16357696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-tumor necrosis factor-alpha-induced psoriasis.
    Sari I; Akar S; Birlik M; Sis B; Onen F; Akkoc N
    J Rheumatol; 2006 Jul; 33(7):1411-4. PubMed ID: 16821276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
    Cohen G; Courvoisier N; Cohen JD; Zaltni S; Sany J; Combe B
    Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.